Patient and donor characteristics
| Patient and disease characteristics . | No. of patients (n = 9) . |
|---|---|
| Median age, (range), y | 43 (29-62) |
| Sex, n | |
| Male | 5 (56%) |
| Female | 4 (44%) |
| Diagnosis, n | |
| SPTCL | 5 (56%) |
| Skin only | 2 (23%) |
| Extracutaneous site∗ | 3 (33%) |
| Primary CGDTCL | 4 (44%) |
| Skin only | 2 (22%) |
| Extracutaneous site∗ | 2 (22%) |
| History of HLH | |
| Yes | 7 (78%) |
| No | 2 (22%) |
| Time from diagnosis to allogeneic HCT, median (range), mo | 10.7 (6.7-44.9) |
| <24 mo | 8 (88%) |
| ≥24 mo | 1 (12%) |
| No. of prior systemic therapies, median (range) | 3 (1-7) |
| Disease status at the time of conditioning, n | |
| CR | 4 (44%) |
| PR | 4 (44%) |
| SD | 1 (12%) |
| Targeted radiation before conditioning | |
| Yes | 4 (44%) |
| No | 5 (56%) |
| Donor, n | |
| HLA-matched sibling | 3 (33%) |
| Haploidentical | 2 (23%) |
| Unrelated | 4 (44%) |
| Matched | 2 (22%) |
| Mismatched† | 2 (22%) |
| Patient and disease characteristics . | No. of patients (n = 9) . |
|---|---|
| Median age, (range), y | 43 (29-62) |
| Sex, n | |
| Male | 5 (56%) |
| Female | 4 (44%) |
| Diagnosis, n | |
| SPTCL | 5 (56%) |
| Skin only | 2 (23%) |
| Extracutaneous site∗ | 3 (33%) |
| Primary CGDTCL | 4 (44%) |
| Skin only | 2 (22%) |
| Extracutaneous site∗ | 2 (22%) |
| History of HLH | |
| Yes | 7 (78%) |
| No | 2 (22%) |
| Time from diagnosis to allogeneic HCT, median (range), mo | 10.7 (6.7-44.9) |
| <24 mo | 8 (88%) |
| ≥24 mo | 1 (12%) |
| No. of prior systemic therapies, median (range) | 3 (1-7) |
| Disease status at the time of conditioning, n | |
| CR | 4 (44%) |
| PR | 4 (44%) |
| SD | 1 (12%) |
| Targeted radiation before conditioning | |
| Yes | 4 (44%) |
| No | 5 (56%) |
| Donor, n | |
| HLA-matched sibling | 3 (33%) |
| Haploidentical | 2 (23%) |
| Unrelated | 4 (44%) |
| Matched | 2 (22%) |
| Mismatched† | 2 (22%) |